海创药业: 关于持股5%以上股东权益变动触及5%刻度的提示性公告

Core Points - Chengdu Yingchuang Power Venture Capital Co., Ltd. has reduced its stake in Haichuang Pharmaceutical Co., Ltd. from 10.67% to 5.00% through share sales between July 12, 2023, and July 31, 2025 [1][2] - The reduction involved a total of 3,878,669 shares sold via centralized bidding and block trading methods [1] - The change in shareholding does not trigger mandatory tender offer obligations and does not violate any prior commitments made by the shareholder [1] Group 1 - The shareholder, Chengdu Yingchuang Power Venture Capital Co., Ltd., has no concerted actions with other shareholders [1] - The shareholding change was officially communicated to Haichuang Pharmaceutical through a notice regarding the reduction of shares [1] - The company confirms that the information provided by the shareholder is accurate and complete [1][2] Group 2 - The shareholding before the reduction was 1,056.84 million shares, which represented 10.67% of the total shares [1] - After the reduction, the remaining shares held by the shareholder are 495.08 million, equating to 5.00% of the total shares [1] - The company is required to comply with relevant regulations regarding the disclosure of shareholding changes [1]